REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

KOSZIRT-PHARMA BT. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: KOSZIRT-PHARMA BT. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

KOSZIRT-PHARMA BT. is a company based in Hungary, with its head office in Vasarosnameny. It operates in the Pharmacies and Drug Stores sector. It was first established on February 22, 1996. KOSZIRT-PHARMA BT. currently employs 8 (2024) people. In 2024, the company reported a net sales revenue increase of 32.63%. During that time, KOSZIRT-PHARMA BT.’s total assets grew by 17.78%. In 2024, KOSZIRT-PHARMA BT.’s net profit margin increased by 1%.

Headquarters
Rakoczi ut 22/a.
Vasarosnameny; Szabolcs-Szatmar-Bereg; Postal Code: 4800

Contact Details: Purchase the KOSZIRT-PHARMA BT. report to view the information.

Basic Information
Total Employees:
Purchase the KOSZIRT-PHARMA BT. report to view the information.
Registered Capital:
Purchase the KOSZIRT-PHARMA BT. report to view the information.
Financial Auditors:
Purchase the KOSZIRT-PHARMA BT. report to view the information.
Incorporation Date:
February 22, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Business Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
AQUILA Gyogyszertar Bt.
Company Performance
Financial values in the chart are available after KOSZIRT-PHARMA BT. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
32.63%▲
Total operating revenue
37.42%▲
Operating profit (EBIT)
54%▲
EBITDA
51.21%▲
Net Profit (Loss) for the Period
39.41%▲
Total Assets
17.78%▲
Total Equity
22.83%▲
Operating Profit Margin (ROS)
2.65%▲
Net Profit Margin
1%▲
Return on Equity (ROE)
3.18%▲
Quick Ratio
0.42%▲
Cash Ratio
-0.14%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo